Literature DB >> 3574134

Homocysteinemia due to folate deficiency.

S S Kang, P W Wong, M Norusis.   

Abstract

We examined the relationship between serum folate and total homocyst(e)ine levels by determining protein-bound homocyst(e)ine in stored serum from 19 subjects with subnormal serum folate (less than 2 ng/mL), 137 subjects with low normal serum folate (between 2.0 and 3.9 ng/mL), 44 subjects with normal serum folate (between 4.0 and 17.9 ng/mL), and 38 subjects with high serum folate (above 18 ng/mL). Eighty-four percent of the subjects with subnormal serum folate and 56% of the subjects with low normal serum folate had more than 7.05 nmol/mL serum total homocyst(e)ine (ie, more than two standard deviations above the normal mean). Thirty-two percent of these subjects had more than a three-fold increase in serum total homocyst(e)ine. These observations support the hypothesis that depletion of tissue folate causes homocysteinemia in nonhomocystinuric subjects. Subnormal as well as low normal concentrations of serum folate appear to produce an accumulation of homocyst(e)ine. In addition, relatively normal levels of serum total homocyst(e)ine were observed in four pregnant women with low serum folate, supporting previous suggestions of an influence of female sex hormone(s) in homocysteine metabolism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3574134     DOI: 10.1016/0026-0495(87)90043-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  42 in total

1.  The effect of a subnormal vitamin B-6 status on homocysteine metabolism.

Authors:  J B Ubbink; A van der Merwe; R Delport; R H Allen; S P Stabler; R Riezler; W J Vermaak
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease.

Authors:  J B Ubbink; W J Vermaak; J M Bennett; P J Becker; D A van Staden; S Bissbort
Journal:  Klin Wochenschr       Date:  1991-08-16

Review 3.  SLC19: the folate/thiamine transporter family.

Authors:  Vadivel Ganapathy; Sylvia B Smith; Puttur D Prasad
Journal:  Pflugers Arch       Date:  2003-05-06       Impact factor: 3.657

4.  A Black Cohosh Extract Causes Hematologic and Biochemical Changes Consistent with a Functional Cobalamin Deficiency in Female B6C3F1/N Mice.

Authors:  Michelle C Cora; William Gwinn; Ralph Wilson; Debra King; Suramya Waidyanatha; Grace E Kissling; Sukhdev S Brar; Dorian Olivera; Chad Blystone; Greg Travlos
Journal:  Toxicol Pathol       Date:  2017-06-15       Impact factor: 1.902

Review 5.  Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives.

Authors:  Klaus K Witte; Andrew L Clark
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

Review 6.  Assessment of homocysteine status.

Authors:  H Refsum; T Fiskerstrand; A B Guttormsen; P M Ueland
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

Review 7.  The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia.

Authors:  J B Ubbink
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

8.  Genetic and lifestyle variables associated with homocysteine concentrations and the distribution of folate derivatives in healthy premenopausal women.

Authors:  Carolyn M Summers; Laura E Mitchell; Anna Stanislawska-Sachadyn; Shirley F Baido; Ian A Blair; Joan M Von Feldt; Alexander S Whitehead
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-08

Review 9.  [Folate against hyperhomocysteinemia. A new approach for the prevention and therapy of alcoholism-associated disorders?].

Authors:  S Bleich; K Löffelholz; J Kornhuber
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

10.  Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.

Authors:  S S Kang; J Zhou; P W Wong; J Kowalisyn; G Strokosch
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.